Tel Aviv, Israel · Founded 2021 · Privately Held (backing)
Operator of an artificial intelligence-based drug delivery company intended to facilitate lipid nanoparticle development for oligonucleotide therapies. Mana.bio is based in Tel Aviv, Israel and was founded in 2021. Its last reported valuation was $30.8 million in Oct 2023. It has raised $19.5 million.
Last reported valuation
$30.8M
Oct 2026
Priced at
—
Total raised
$19.5M
Last round
—
Cap table — not yet on record
Mana.bio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Mana.bio with a free account
·Watch Mana.bio: the Monday email on marks, rounds and moves
